ANGLE plc (ANPCF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.66 Million GBP | 56.63% |
| 2022 | -26.89 Million GBP | 8.83% |
| 2021 | -29.5 Million GBP | -175.25% |
| 2020 | -10.71 Million GBP | -386.3% |
| 2019 | -2.2 Million GBP | 79.98% |
| 2018 | -11.01 Million GBP | -44.02% |
| 2017 | -7.64 Million GBP | -38.1% |
| 2016 | -5.53 Million GBP | -47.08% |
| 2015 | -3.76 Million GBP | 55.42% |
| 2014 | -8.44 Million GBP | -116.6% |
| 2013 | -3.89 Million GBP | -129.84% |
| 2012 | -1.69 Million GBP | -71.31% |
| 2011 | -990 Thousand GBP | -149.37% |
| 2010 | -397 Thousand GBP | 47.0% |
| 2009 | -749 Thousand GBP | -75000.0% |
| 2008 | 1000.00 GBP | 100.12% |
| 2007 | -840 Thousand GBP | 66.77% |
| 2006 | -2.52 Million GBP | 69.13% |
| 2005 | -8.18 Million GBP | 0.0% |
| 2004 | -8.18 Million GBP | 0.63% |
| 2003 | -8.24 Million GBP | -10072.84% |
| 2002 | -81 Thousand GBP | 88.07% |
| 2001 | -679 Thousand GBP | 31.0% |
| 2000 | -984 Thousand GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -17.88 Million GBP | 23.6% |
| 2024 Q1 | -17.88 Million GBP | -53.31% |
| 2023 Q1 | -18.2 Million GBP | 32.33% |
| 2023 FY | -11.66 Million GBP | 56.63% |
| 2023 Q3 | -12.31 Million GBP | 29.99% |
| 2023 Q4 | -11.66 Million GBP | 5.27% |
| 2023 Q2 | -17.58 Million GBP | 3.37% |
| 2022 Q3 | -27.55 Million GBP | -80.58% |
| 2022 Q2 | -15.26 Million GBP | 3.57% |
| 2022 Q1 | -15.82 Million GBP | 46.36% |
| 2022 FY | -26.89 Million GBP | 8.83% |
| 2022 Q4 | -26.89 Million GBP | 2.4% |
| 2021 Q2 | -6.87 Million GBP | 9.04% |
| 2021 Q4 | -29.5 Million GBP | 1.74% |
| 2021 FY | -29.5 Million GBP | -175.25% |
| 2021 Q1 | -7.55 Million GBP | 29.51% |
| 2021 Q3 | -30.02 Million GBP | -336.89% |
| 2020 Q2 | -12.17 Million GBP | 0.0% |
| 2020 Q4 | -10.71 Million GBP | 3.89% |
| 2020 Q3 | -11.15 Million GBP | 8.4% |
| 2020 FY | -10.71 Million GBP | -386.3% |
| 2020 Q1 | -12.17 Million GBP | 0.0% |
| 2019 Q3 | -18.91 Million GBP | -27.14% |
| 2019 Q1 | -11.01 Million GBP | 0.0% |
| 2019 FY | -2.2 Million GBP | 79.98% |
| 2019 Q2 | -14.87 Million GBP | -35.1% |
| 2018 Q1 | -7.64 Million GBP | 0.0% |
| 2018 Q3 | -14.87 Million GBP | 0.0% |
| 2018 FY | -11.01 Million GBP | -44.02% |
| 2018 Q4 | -11.01 Million GBP | 25.98% |
| 2017 Q4 | -7.64 Million GBP | -78.58% |
| 2017 Q3 | -4.28 Million GBP | 0.0% |
| 2017 Q2 | -4.28 Million GBP | 22.67% |
| 2017 Q1 | -5.53 Million GBP | 0.0% |
| 2017 FY | -7.64 Million GBP | -38.1% |
| 2016 Q2 | -9.65 Million GBP | -156.4% |
| 2016 Q1 | -3.76 Million GBP | 0.0% |
| 2016 Q3 | -9.65 Million GBP | 0.0% |
| 2016 Q4 | -5.53 Million GBP | 42.64% |
| 2016 FY | -5.53 Million GBP | -47.08% |
| 2015 FY | -3.76 Million GBP | 55.42% |
| 2015 Q2 | -5.82 Million GBP | 30.97% |
| 2015 Q3 | -5.82 Million GBP | 0.0% |
| 2015 Q4 | -3.76 Million GBP | 35.42% |
| 2015 Q1 | -8.44 Million GBP | 0.0% |
| 2014 Q3 | -2.26 Million GBP | 0.0% |
| 2014 Q4 | -8.44 Million GBP | -272.27% |
| 2014 FY | -8.44 Million GBP | -116.6% |
| 2014 Q2 | -2.26 Million GBP | 41.82% |
| 2014 Q1 | -3.89 Million GBP | 0.0% |
| 2013 FY | -3.89 Million GBP | -129.84% |
| 2013 Q2 | -226 Thousand GBP | 86.67% |
| 2013 Q3 | -226 Thousand GBP | 0.0% |
| 2013 Q4 | -3.89 Million GBP | -1624.78% |
| 2013 Q1 | -1.69 Million GBP | 0.0% |
| 2012 FY | -1.69 Million GBP | -71.31% |
| 2012 Q4 | -1.69 Million GBP | -114.78% |
| 2012 Q3 | -789.63 Thousand GBP | 0.0% |
| 2012 Q2 | -789.63 Thousand GBP | 20.16% |
| 2012 Q1 | -989 Thousand GBP | 0.0% |
| 2011 FY | -990 Thousand GBP | -149.37% |
| 2011 Q3 | -961 Thousand GBP | 0.0% |
| 2011 Q1 | -397 Thousand GBP | 0.0% |
| 2010 Q3 | -668 Thousand GBP | 0.0% |
| 2010 FY | -397 Thousand GBP | 47.0% |
| 2010 Q1 | -749 Thousand GBP | 0.0% |
| 2009 Q3 | -463 Thousand GBP | 0.0% |
| 2009 Q1 | 1000.00 GBP | 0.0% |
| 2009 FY | -749 Thousand GBP | -75000.0% |
| 2008 FY | 1000.00 GBP | 100.12% |
| 2008 Q3 | -212 Thousand GBP | 0.0% |
| 2008 Q1 | -839 Thousand GBP | 0.0% |
| 2007 FY | -840 Thousand GBP | 66.77% |
| 2007 Q3 | -983 Thousand GBP | 0.0% |
| 2007 Q1 | -2.52 Million GBP | 0.0% |
| 2006 Q1 | -8.18 Million GBP | 0.0% |
| 2006 FY | -2.52 Million GBP | 69.13% |
| 2006 Q3 | -4.29 Million GBP | 0.0% |
| 2005 Q1 | -5.52 Million GBP | 0.0% |
| 2005 FY | -8.18 Million GBP | 0.0% |
| 2005 Q3 | -3.2 Million GBP | 0.0% |
| 2004 Q3 | -7.23 Million GBP | 0.0% |
| 2004 Q1 | -8.24 Million GBP | 0.0% |
| 2004 FY | -8.18 Million GBP | 0.63% |
| 2003 FY | -8.24 Million GBP | -10072.84% |
| 2003 Q3 | -3000.00 GBP | 0.0% |
| 2002 FY | -81 Thousand GBP | 88.07% |
| 2001 FY | -679 Thousand GBP | 31.0% |
| 2000 FY | -984 Thousand GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 628.74% |
| Arrayit Corporation | 1.05 Million USD | 1204.985% |
| Atlantic International Corp. | 236.49 Thousand USD | 5032.007% |
| Biocept, Inc. | -788 Thousand USD | -1380.203% |
| Bioqual, Inc. | -12 Million USD | 2.858% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 51395.132% |
| DermTech, Inc. | 17.65 Million USD | 166.074% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 97.963% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | -58.115% |
| iMD Companies, Inc. | 1.11 Million USD | 1145.242% |
| IDenta Corp. | 524.85 Thousand USD | 2322.341% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 251.599% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -43176.937% |
| InVitro International | -313.14 Thousand USD | -3624.828% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 844.868% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -1635804.628% |
| Medical Imaging Corp. | 3.79 Million USD | 407.681% |
| NovelStem International Corp. | 3.52 Million USD | 431.219% |
| Optigenex Inc. | 8.93 Million USD | 230.558% |
| PharmChem, Inc. | -1.49 Million USD | -680.507% |
| Proteome Sciences plc | 14.57 Million USD | 180.037% |
| Response Genetics, Inc | -13.08 Million USD | 10.867% |
| Rennova Health, Inc. | 14.82 Million USD | 178.652% |
| RushNet, Inc. | 4.8 Million USD | 342.957% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 8702.468% |
| Stella Diagnostics Inc. | 6.19 Million USD | 288.34% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 753.665% |
| Todos Medical Ltd. | 38.31 Million USD | 130.443% |